鼻下型与鼻上型面罩在急性高碳酸血症性呼吸衰竭无创通气中预防面部压疮的随机对照试验
这项多中心前瞻性随机对照研究纳入两家法国三级医院ICU的108例因急性高碳酸血症性呼吸衰竭需无创通气的患者,1:1随机接受鼻下型面罩(干预组)或鼻上型面罩(对照组)。主要终点为面部压疮发生率:鼻下型组3例(5%)显著低于鼻上型组39例(74%)(p<0.001),尽管干预组使用保护性敷料更少(4例,5% vs 27例,51%;p<0.001)。两组死亡率、无创通气失败率和动脉血气改善相似,但鼻下型组接口失败率更高(18例,33% vs 5例,9%;p=0.004),主要因过度非故意漏气(15例,83% vs 0例,0%;p<0.001)。结论提示鼻下型面罩可减少压疮,但漏气问题更常迫使临床医生更换接口。
要点
- 鼻下型面罩组面部压疮发生率5%(3/108)显著低于鼻上型组74%(39/108)(p<0.001)。
- 鼻下型组接口失败率33%(18/108)高于鼻上型组9%(5/108)(p=0.004),主要因过度非故意漏气(83% vs 0%;p<0.001)。
- 两组死亡率、无创通气失败率及动脉血气改善相似。
- 鼻下型组使用保护性敷料更少(5% vs 51%;p<0.001),但压疮仍更少。
适用人群与场景
- 因急性高碳酸血症性呼吸衰竭需要无创通气的成人患者,来自两家法国三级医院ICU(共108例)。
处置流程与药物剂量
- 干预组使用鼻下型面罩作为一线接口进行无创通气,对照组使用标准鼻上型面罩。
- 当出现过度非故意漏气时,临床医生需更换为其他接口(如全脸面罩)以继续无创通气。
红旗征与不能漏的情况
- 鼻下型面罩出现过度非故意漏气时需警惕接口失败,本研究中该组83%的接口失败由漏气导致。
研究设计与关键结果
- 多中心前瞻性随机对照研究,纳入两家法国三级医院ICU的108例急性高碳酸血症性呼吸衰竭需无创通气患者,1:1随机分为鼻下型面罩组和鼻上型面罩组。
- 主要终点面部压疮发生率:鼻下型组5%(3例) vs 鼻上型组74%(39例),p<0.001。
- 保护性敷料使用:鼻下型组5%(4例) vs 鼻上型组51%(27例),p<0.001。
- 接口失败率:鼻下型组33%(18例) vs 鼻上型组9%(5例),p=0.004。
- 接口失败原因中过度非故意漏气:鼻下型组83%(15例) vs 鼻上型组0%(0例),p<0.001。
- 两组死亡率、无创通气失败率及动脉血气改善相似。
证据类型、等级与局限
- 证据类型:多中心、前瞻性随机对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在急性高碳酸血症性呼吸衰竭需无创通气的患者中,鼻下型面罩可显著降低面部压疮发生率,但临床医生需注意其因过度非故意漏气导致的更高接口失败率,可能需要更换接口。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether an under-the-nose face mask (FM) as the first-line interface strategy reduces the incidence of facial pressure sores with the same clinical improvement as the one obtained by standard over-the-nose face mask-noninvasive ventilation (FM-NIV) in patients with acute hypercapnic respiratory failure (AHRF).
DESIGN: A multicenter, prospective randomized controlled study.
SETTING: Two ICUs from two French tertiary hospitals.
PATIENTS: A total of 108 patients needed NIV for AHRF.
INTERVENTIONS: participants were randomized (1/1) to receive either the under-the-nose FM (intervention group) or the over-the-nose FM (control group). The primary endpoint was the reduction of facial pressure sores. Secondary endpoints included patients outcome, NIV failure (intubation or death), arterial blood gas improvement, and interface failure (the need to switch to a total face mask).
MEASUREMENTS AND MAIN RESULTS: Despite less protective dressings in the intervention group ( n = 4, 5% vs n = 27, 51%; p < 0.001), pressure sores developed less frequently than in the control group ( n = 3, 5% vs n = 39, 74%; p < 0.001). Similar mortality, NIV failure, and arterial blood gas improvement occurred in the two groups. However, under-the-nose FM resulted in a higher interface failure rate than conventional FM ( n = 18, 33% vs n = 5, 9%; p = 0.004), mainly because of excessive unintentional air leaks ( n = 15, 83% vs n = 0, 0%; p < 0.001).
CONCLUSIONS: In patients with AHRF, under-the-nose FM significantly reduced the incidence of facial pressure sores compared to the most commonly used first-line interface, the standard FM. However, with this new mask, excessive unintentional air leaks more often compelled the attending clinician to switch to another interface to pursue NIV.
参考来源
- Lemyze M, Mallat J, Vangrunderbeek N, et al. Under-The-Nose Versus Over-The-Nose Face Mask to Prevent Facial Pressure Sores During Face Mask-Delivered Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure: A Randomized Controlled Trial. Crit Care Med. 2023. PMID: 37166242. doi:10.1097/CCM.0000000000005902
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。